Roche Anti-Sars Recombinant Protein To Nucleocapsid Antigen

Mouse Monoclonal Anti-SARS Nucleocapsid protein IgG

AB-17810 50 ug
EUR 562.8

Human IgG antibody Laboratories manufactures the roche anti-sars recombinant protein to nucleocapsid antigen reagents distributed by Genprice. The Roche Anti-Sars Recombinant Protein To Nucleocapsid Antigen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Recombinant. Other Roche products are available in stock. Specificity: Roche Category: Anti-Sars Group: Recombinant Protein

SARS Nucleocapsid antibody

100 ug
EUR 451
Description: Mouse monoclonal SARS Nucleocapsid antibody

SARS Nucleocapsid antibody

100 ug
EUR 451
Description: Mouse monoclonal SARS Nucleocapsid antibody

SARS Nucleocapsid Antibody

0.1 mg
EUR 362.5

SARS Nucleocapsid Antibody

100 tests
EUR 1237.5

SARS Nucleocapsid Antibody

100 tests
EUR 362.5

SARS Nucleocapsid

5µg
EUR 175
Description: Polyclonal Rabbit Anti SARS Nucleocapsid Protein

SARS Nucleocapsid

5µg
EUR 175
Description: Mouse Anti SARS Nucleocapsid

Recombinant Protein information

Recombinant SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta) Protein

RP01509LQ 100μg
EUR 201.5

SARS Coronavirus Nucleocapsid Recombinant protein (1-49 aa)

39-105 0.05 mg
EUR 556.8
Description: The SARS Nucleocaspid is a protein that has a crucial structural importance, by making the virions associates with the RNA genome and therefore create a nucleocapsid that has the specific helical form. There has been found 3 different domain structures to the nucleocapsid antigen. This protein contains 3 outer structural proteins, the membrane (M), envelope (E), and spike (S) proteins. 

SARS-CoV-2 Nucleocapsid Protein, recombinant CK 6404-b

CK-6404 1 mg
EUR 885
Description: SARS-CoV-2 Nucleocapsid Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

92-728 1 mg
EUR 1023
Description: Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

97-077 0.1 mg
EUR 821.4
Description: Nucleocapsid protein is a most abundant protein of coronavirus. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. While screening for ADP-ribosylated proteins during coronavirus (CoV) infection, we identified as the viral nucleocapsid (N) protein. Novel post-translation modification of the CoV N protein that may play a regulatory role for this important structural protein. The array of diverse functional activities accommodated in the hantaviral N protein goes far beyond to be a static structural protein and makes it an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

97-085 0.1 mg
EUR 789.9
Description: Nucleocapsid protein is a most abundant protein of coronavirus. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. While screening for ADP-ribosylated proteins during coronavirus (CoV) infection, we identified as the viral nucleocapsid (N) protein. Novel post-translation modification of the CoV N protein that may play a regulatory role for this important structural protein. The array of diverse functional activities accommodated in the hantaviral N protein goes far beyond to be a static structural protein and makes it an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

10-113 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

10-306 0.1 mg
EUR 632.4
Description: SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

10-410 0.1 mg
EUR 651.3
Description: Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

10-434 0.1 mg
EUR 714.3
Description: Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

11-186 0.2 mg
EUR 1212
Description: Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

11-214 0.2 mg
EUR 1212
Description: Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool.

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

20-204 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

20-229 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant Protein

SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant protein

39-113 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS Nucleocapsid Recombinant Protein N-terminal His Tag

ISARSNTRNHIS100UL each
EUR 899
Description: SARS Nucleocapsid Recombinant Protein N-terminal His Tag

COVID-19 Nucleocapsid recombinant antigen

00221-V 1 MG
EUR 850